Global Hormone Replacement Therapy Market Research Report 2020

Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo Nordisk, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 players combined 45.13% market share in all.

The global Hormone Replacement Therapy market is valued at 15950 million US$ in 2020 is expected to reach 17720 million US$ by the end of 2026, growing at a CAGR of 1.5% during 2021-2026.
This report focuses on Hormone Replacement Therapy volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hormone Replacement Therapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and Middle East etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Hormone Replacement Therapy market is segmented into
Estrogen Hormone
Growth Hormone
Thyroid Hormone
Testosterone Hormone
The proportion of estrogen hormone in 2018 is about 50%, and the proportion is in increasing trend from 2014 to 2018.

Segment by Application
Menopause
Hypothyroidism
Growth Hormone Deficiency
Male Hypogonadism
Other Diseases
The most proportion of hormone replacement therapy is used in menopause, and the proportion in 2018 is 46.2%.

Global Hormone Replacement Therapy Market: Regional Analysis
The Hormone Replacement Therapy market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Hormone Replacement Therapy market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Hormone Replacement Therapy Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Hormone Replacement Therapy market include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD